Clinical Trials Directory

Trials / Completed

CompletedNCT00392236

Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers

2-Way Pagers to Improve Schizophrenia Medication Adherence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will determine whether using a pager improves medication adherence in people with schizophrenia.

Detailed description

Schizophrenia is a life-long brain disorder affecting approximately 1 percent of Americans each year. Schizophrenia can be extremely disabling, causing people to hear voices, experience paranoia or hallucinations, and believe that others are controlling their thoughts. Many people with schizophrenia have difficulty with remembering their scheduled doctor's appointments and with taking their medication on time because of their mental illness. Many approved medications for schizophrenia must be taken several times a day and side effects such as drowsiness, dizziness, and even weight gain can deter a person from consistently taking their medication on time. Therefore, this study will determine whether a 2-way pager will help people with schizophrenia to remember their doctor's appointments and to take their medication on time. Participants in this open-label study will first complete several written tests to assess skills such as memory, attention, and problem solving. Participants will also be asked questions regarding their current symptoms and medication regimen. Participants will then be randomly assigned to receive either treatment as usual or treatment as usual and a 2-way pager for 6 months. Participants who receive a 2-way pager will attend approximately four information sessions. During these sessions, participants will learn how to program the pager and use a specially designed medication bottle cap that will record the number of bottle openings and the date and time of each opening. At designated times, the pager will vibrate or beep, alerting participants to take their medication or attend a scheduled appointment. All participants will meet weekly with a staff member for the first month and then once a month for the remaining 5 months to complete several brief questionnaires on pager use, assess medication adherence, and discuss any symptoms experienced within the past week or month. Participants will be required to bring their medication to each meeting to ensure compliance.

Conditions

Interventions

TypeNameDescription
DEVICE2-way pagerParticipants will receive messages daily to take their medication via a 2-way pager for 6 months. Once the message is received the participant will respond whether or not he/she took the medication and reason for not taking.
BEHAVIORALTreatment as usualParticipants will receive treatment as usual.

Timeline

Start date
2006-04-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2006-10-25
Last updated
2017-10-25
Results posted
2014-04-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00392236. Inclusion in this directory is not an endorsement.